If you suffered losses in SCYNEXIS stock, contact SCYNEXIS stock loss lawyer Timothy L. Miles about a SCYNEXIS class action lawsuit
introduction to the SCYNEXIS CLASS ACTION LAWSUIT
The SCYNEXIS class action lawsuit seeks to represent purchasers or acquirers of SCYNEXIS, Inc. (NASDAQ: SCYX) securities between March 31, 2023 and September 22, 2023, inclusive (the “Class Period”). Captioned Feldman v. SCYNEXIS, Inc., No. 23-cv-22082 (D.N.J.), the SCYNEXIS class action lawsuit charges SCYNEXIS and certain of its top executive officers with violations of the Securities Exchange Act of 1934.
If you suffered losses in SCYNEXIS stock and wish to serve as lead plaintiff in the SCYNEXIS class action lawsuit, please contact SCYNEXIS Stock Loss Lawyer Timothy L. Miles by calling 855/846-6529 or via e-mail at [email protected] or by submitting a contact form. Lead plaintiff motions for the SCYNEXIS class action lawsuit must be filed with the court no later than January 8, 2024. In this comprehensive analysis, we will discuss what every SCYNEXIS investor needs to know about the SCYNEXIS class action lawsuit. the ALLEGATIONS IN THE SCYNEXIS CLASS ACTION LAWSUIT
The SCYNEXIS class action lawsuit alleges that defendants throughout the Class Period made false and/or misleading statements and/or failed to disclose that: (i) the equipment used to manufacture ibrexafungerp was also used to manufacture a non-antibacterial beta-lactam drug substance, presenting a risk of cross-contamination; (ii) SCYNEXIS did not have effective internal controls and procedures, as well as adequate internal oversight policies to ensure that its vendor complied with current Good Manufacturing Practices; and (iii) due to the substantial risk of cross-contamination, SCYNEXIS was reasonably likely to recall its ibrexafungerp tablets and halt its clinical studies.
The SCYNEXIS class action lawsuit further alleges that on September 25, 2023, SCYNEXIS revealed that following a recent review by GSK plc of the manufacturing process and equipment at the vendor that manufactures the ibrexafungerp drug substance, SCYNEXIS became aware of potential cross contamination of ibrexafungerp with a non-antibacterial beta-lactam drug substance. SCYNEXIS declared it would conduct a recall of BREXAFEMME from the market and place a temporary hold on clinical studies of ibrexafungerp, including a Phase 3 clinical study, until a mitigation strategy and a resupply plan are determined, according to the complaint. The SCYNEXIS class action lawsuit alleges that on this news, the price of SCYNEXIS stock fell more than 41% over two trading sessions. THE LEAD PLAINTIFF DEADLINE IN THE SCYNEXIS CLASS ACTION LAWSUIT
When a securities class action is filed such as the SCYNEXIS class action lawsuit, the person who files the first complaint is required to publish a notice announcing the filing. Anyone who wants to be lead plaintiff on behalf of the class in the SCYNEXIS class action lawsuit must thereafter file a motion to be appointed as lead plaintiff(s) no later than 60 days after the notice was published.
THE LEAD PLAINTIFF PROCESS IN THE SCYNEXIS CLASS ACTION LAWSUIT
The Private Securities Litigation Reform Act of 1995 permits any investor who purchased and suffered losses in SCYNEXIS stock to seek appointment as lead plaintiff in the SCYNEXIS class action lawsuit. A lead plaintiff is generally the movant with the greatest financial interest in the relief sought by the putative class who is also typical and adequate of the putative class.
A lead plaintiff acts on behalf of all other class members in directing the class action lawsuit. The lead plaintiff can select a law firm of its choice to litigate the securities class action lawsuit. An investor’s ability to share in any potential future recovery of the class action lawsuit is not dependent upon serving as lead plaintiff. If you suffered losses in SCYNEXIS stock and have further questions, contact SCYNEXIS class action lawsuit Timothy L. Miles today who will fight to recover your damages in a SCYNEXIS class action lawsuit if you suffered losses in SCYNEXIS stock. A NON-U.S. INVESTOR may SERVE AS LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT IF THEY SUFFERED LOSSES IN SCYNEXIS STOCK
Yes, courts in the U.S. have consistently recognized that non-U.S. investors, many of whom have substantial holdings, are adequate lead plaintiffs and have the same right to move for lead plaintiffs as U.S. investors. Thus, if a non-U.S. investor suffered losses in SCYNEXIS stock, they may move the Court to be appointed lead plaintiff in the SCYNEXIS class action lawsuit.
WHAT ARE THE BENEFITS OF SERVING AS LEAD PLAINTIFF IN THE SCYNEXIS CLASS ACTION LAWSUIT
Serving as a Lead Plaintiff in the SCYNEXIS class action lawsuit has several advantages and important benefits including:
Thus, there are numerous benefits and other advantages to serving as lead plaintiff in a class action against SCYNEXIS if you suffered losses in SCYNEXIS stock. RESPONSIBILITIES THE LEAD PLAINTIFF WILL HAVE IN THE SCYNEXIS CLASS ACTION LAWSUIT
A Lead Plaintiff owes a fiduciary duty to the class, and therefore, must act in the best interest of the class in the SCYNEXIS class action lawsuit. Some of the responsibilities of the Lead Plaintiff in the SCYNEXIS class action lawsuit include:
tHE LEAD PLAINTIFFS will not GET MORE MONEY THAN CLASS MEMBERS IF THE SCYNEXIS CLASS ACTION LAWSUIT
But they may be entitled to recover their reasonable expenses incurred with are directly related to representing the class in the SCYNEXIS class action lawsuit. Under the Private Securities Litigation Reform Act of 1995, a Lead Plaintiff is only entitled to his or her pro rata share of any recovery and does not receive any additional money for serving as a representative party on behalf of the class. However, a court, in its discretion, may approve an award of “reasonable costs and expenses (including lost wages)” to a Lead Plaintiff that directly relates to the representation of the class in the SCYNEXIS class action lawsuit on behalf of investors who suffered losses in SCYNEXIS stock.
THE COURT may APPOINT MORE THAN ONE LEAD PLAINTIFF IN THE SCYNEXIS LAWSUIT
Yes, at its discretion the Court may appoint a person, entity, or group of persons and/or entities as Lead Plaintiffs to oversee the SCYNEXIS lawsuit.
THE CLASS PERIOD DETERMINation IN THE SCYNEXIS LAWSUIT
In a securities fraud class action, the class period refers to a period of time in which it is alleged the price of the company’s stock was artificially inflated due to false and misleading statements made by company executives. The class period starts when the company makes an untrue statement of material fact about the company or fails to disclose a material fact necessary to render other statements not misleading. The class period ends when the truth is revealed to the investing public through a corrective disclosure.
In order to be a part of the class in the SCYNEXIS lawsuit, you must have suffered losses in SCYNEXIS stock by purchasing during the class period when it is alleged the price of the stock was artificially inflated to be included in the class action against SCYNEXIS. HOW A SCYNEXIS STOCK LOSS LAWYER CAN help you
A SCYNEXIS stock loss Lawyer is well-versed in the complex laws that govern the securities industry and litigation and focuses on representing individual investors or funds who have been the victims of fraud or who have disputes with investment professionals. Ordinary individual investors, including civil servants, teachers, nurses, and retirees, may need a securities lawyer. In most cases, they have lost money due to mistakes, incompetence, or fraud by an investment professional.
While FINRA, the SEC, and state securities regulators serve a vital role in protecting investors, they simply have too many individuals, firms, and market transactions to monitor to discover every act of fraud or negligence. Individual investors should consult with a securities lawyer if they have lost money due to fraud or stockbroker misconduct. Look for a securities lawyer with experience, high ethical standards, verifiable credentials, and a trustworthy reputation among his peers and the judiciary, as well as testimonials from previous clients and awards and recognitions. One name that immediately pops up is nationally known and widely respected Nashville lawyer Timothy L. Miles, who has valuable experience and has received numerous awards, mostly due to his high ethical standards, and hard work ethic, including most recently being named a Top 25 Class action lawyer by the National Trial Lawyers Association, and has maintained an AV rating from Martindale-Hubble since 2014, was named a 2023 Top Rated Litigator and 2023 Top Rated Lawyer by Martindale-Hubble and ALM, and was recently named a 2023 Elite Lawyer of the South by Martindale-Hubble for the fifth year in a row, and was a recipient of Avvo Client’s Choice Award in 2021, in 2022 was featured in the Top 100 Lawyers Magazine and received the Lifetime Achievement Award by Premier Lawyers of America (2019–2021). This will most likely be the only call you need to make. (855) 846–6529 or [email protected]. CONTACT A SCYNEXIS STOCK LOSS LAWYER TODAY IF YOU SUFFERED LOSSES IN SCYNEXIS STOCK ABOUT A SCYNEXIS CLASS ACTION LAWSUIT
If you suffered losses in SCYNEXIS stock, contact SCYNEXIS stock loss lawyer Timothy L. Miles today for a free case evaluation about a SCYNEXIS class action lawsuit. Call today and see what a SCYNEXIS stock loss lawyer could do for you if you suffered losses in SCYNEXIS stock.
SCYNEXIS stock loss lawyer Timothy L. MilesNashville attorney Timothy L. Miles is a nationally recognized shareholder rights attorney raised in Nashville, Tennessee. Mr. Miles has dedicated his career to representing shareholders, employees, and consumers in complex class-action litigation. Whether serving as lead, co-lead, or liaison counsel, Mr. Miles has helped recover hundreds of millions of dollars for defrauded investors, shaped precedent-setting decisions, and delivered real corporate governance reforms. Judges and peers have repeatedly recognized Mr. Miles’ relentless advocacy for the underdog, as well as his unbendable ethical standards. Mr. Miles was recently selected by Martindale-Hubbell® and ALM as a 2022 Top Ranked Lawyer, 2022 Top Rated Litigator. and a 2022 Elite Lawyer of the South. Mr. Miles also maintains the AV Preeminent Rating by Martindale-Hubbell®, their highest rating for both legal ability and ethics. Mr. Miles is a member of the prestigious Top 100 Civil Plaintiff Trial Lawyers: The National Trial Lawyers Association,Class Action: Class Action: Top National Trial Lawyers, National Trial Lawyers Association (2023), a superb rated attorney by Avvo, a recipient of the Lifetime Achievement Award by Premier Lawyers of America (2019) and recognized as a Distinguished Lawyer, Recognizing Excellence in Securities Law, by Lawyers of Distinction (2019); a Top Rated Litigator by Martindale-Hubbell® and ALM (2019-2022); America’s Most Honored Lawyers 2020 – Top 1% by America’s Most Honored (2020-2022). Mr. Miles has published over sixty articles on various issues of the law, including class actions, whistleblower cases, products liability, civil procedure, derivative actions, corporate takeover litigation, corporate formation, mass torts, dangerous drugs, and more. Please visit our website or call for free anytime. Comments are closed.
|
AuthorWrite something about yourself. No need to be fancy, just an overview. Archives
October 2024
Categories
All
|
CONTACT
The Law Offices of Timothy L. Miles Tapestry at Brentwood Town Center 300 Centerview Dr., #247 Brentwood, TN 37027 Phone: (855) 846-6529 Email: [email protected] HOURS OF OPERATION Mon-Fri: 24/7 Sat-Sun: 24/7 |
SECURITIES FRAUD
GitLab, Inc. Acadia Healthcare Sunlight Financial Iris Energy Limited Edwards Lifesciences Elanco Animal Health, Inc. MASS TORTS
Takata Airbag Settlement |